Literature DB >> 19810886

Role of clobazam in the treatment of epilepsies.

Maria Augusta Montenegro1, Carlos A M Guerreiro.   

Abstract

The antiepileptic effect of clobazam was first described in 1973. The main advantages of clobazam as an antiepileptic drug are its fast-onset of action and effect against a wide variety of seizures. Despite sometimes losing its effectiveness after a previous period in which it has been effective, clobazam may keep its antiepileptic effect when used intermittently. Tolerance is much more common with benzodiazepines than the other antiepileptic drugs. Although tolerance to clobazam does occur, sustained responders have been identified, and many patients maintain their controlled seizures for several months. Clobazam is a safe drug, and its efficacy is probably equivalent to that of the new antiepileptic drugs. Therefore, it should be considered as add-on medication in the treatment of epilepsy. Clobazam is rapidly and completely absorbed and can be used intermittently, especially for catamenial epilepsy and in patients with clusters of seizures, but only during periods of seizure exacerbation.

Entities:  

Year:  2003        PMID: 19810886     DOI: 10.1586/14737175.3.6.829

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  4 in total

Review 1.  Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

Authors:  Jose de Leon; Edoardo Spina; Francisco J Diaz
Journal:  Ther Drug Monit       Date:  2013-02       Impact factor: 3.681

Review 2.  Clobazam add-on therapy for drug-resistant epilepsy.

Authors:  Rebecca Bresnahan; Kirsty J Martin-McGill; John Williamson; Benedict D Michael; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-10-22

3.  Seizures in patients with cerebral hemiatrophy: A prognostic evaluation.

Authors:  Anupam Jaiswal; Ravindra Kumar Garg; Hardeep Singh Malhotra; Rajesh Verma; Maneesh Kumar Singh
Journal:  Ann Indian Acad Neurol       Date:  2015 Jan-Mar       Impact factor: 1.383

4.  Does orally dissolving formulation of clobazam provide clinical advantage over it's standard formulation.

Authors:  Anant Dhondopant Patil
Journal:  Indian J Pharmacol       Date:  2016 May-Jun       Impact factor: 1.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.